Patient experiences of participation in a radical thoracic surgical trial: findings from the Mesothelioma and Radical Surgery Trial 2 (MARS 2)

• Published in: Current controlled trials in cardiovascular medicine Vol. 20; no. 1; pp. 598 - 10
• Main Authors: Warnock, Clare, Lord, Karen, Taylor, Bethany, Tod, Angela
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 18.10.2019; BioMed Central; BMC
• Subjects: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols - adverse effects; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Cancer; Cancer therapies; Cancer treatment; Care and treatment; Chemotherapy; Chemotherapy, Adjuvant; Clinical trials; Comparative analysis; Comprehension; Consent; Data collection; England; Female; Health Knowledge, Attitudes, Practice; Health Literacy; Humans; Interviews; Interviews as Topic; Longitudinal Studies; Male; Medical personnel; Medical research; Mesothelioma; Mesothelioma - therapy; Middle Aged; Participation; Patient outcomes; Patient Participation; Patient Satisfaction; Patients; Qualitative Research; Randomisation; Randomized Controlled Trials as Topic; Research Subjects - psychology; Retirement benefits; Surgery; Thoracic surgery; Thoracic Surgical Procedures - adverse effects; Treatment Outcome; England; United Kingdom; United Kingdom > UK; Clinical trials; Mesothelioma; Randomisation; Chemotherapy; Surgery

The Mesothelioma and Radical Surgery Trial (MARS 2) aims to evaluate a surgical procedure by comparing chemotherapy and surgery against chemotherapy alone. The pilot study for MARS 2 evaluated the viability of recruitment. Challenges have been reported in conducting clinical research into thoracic s...